抗真菌异质性耐药导致预防失败并促进突破性近平滑念珠菌感染
在接受米卡芬净预防的高危异基因造血干细胞移植(allo-HCT)受者中,突破性血流感染由近平滑念珠菌异质性耐药(约万分之一低频耐药亚群)所致。分析北美、欧洲和亚洲219株临床分离株显示米卡芬净异质性耐药广泛存在,常规药敏试验无法检出;研究者构建机器学习框架,最多用十个基因组特征即可分类异质性耐药或敏感。
要点
- 异质性耐药(约万分之一低频耐药亚群)可解释allo-HCT受者米卡芬净预防下的突破性近平滑念珠菌血流感染。
- 北美、欧洲和亚洲219株临床分离株显示近平滑念珠菌米卡芬净异质性耐药广泛存在。
- 肉汤微量稀释法和梯度扩散法均无法检出近平滑念珠菌米卡芬净异质性耐药。
核心结论
- 异质性耐药与allo-HCT受者中无法解释的抗真菌预防失败相关,并展示了一种有潜力指导临床决策的概念验证诊断方法。
研究设计与样本
- 研究纳入接受米卡芬净预防的高危allo-HCT受者,并分析来自北美、欧洲和亚洲的219株临床分离株。
- 构建预测性机器学习框架,最多使用十个基因组特征将分离株分类为异质性耐药或敏感。
主要发现
- 异质性耐药表现为表型不稳定的低频耐药细胞亚群(约万分之一),可导致近平滑念珠菌突破性血流感染。
- 分析219株临床分离株显示近平滑念珠菌中米卡芬净异质性耐药广泛存在。
- 肉汤微量稀释法和梯度扩散法等标准抗菌药物敏感性试验无法检出近平滑念珠菌米卡芬净异质性耐药。
关键数值与推荐
- 机器学习框架最多使用十个基因组特征即可将分离株分类为异质性耐药或敏感。
临床怎么用
- 作者认为该概念验证诊断方法具有指导临床决策和改善患者护理的潜力。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Breakthrough fungal infections in patients on antimicrobial prophylaxis during allogeneic hematopoietic cell transplantation (allo-HCT) represent a major and often unexplained cause of morbidity and mortality. Candida parapsilosis is a common cause of invasive candidiasis and has been classified as a high-priority fungal pathogen by the World Health Organization. In high-risk allo-HCT recipients on micafungin prophylaxis, we show that heteroresistance (the presence of a phenotypically unstable, low-frequency subpopulation of resistant cells (~1 in 10,000)) underlies breakthrough bloodstream infections by C. parapsilosis. By analyzing 219 clinical isolates from North America, Europe and Asia, we demonstrate widespread micafungin heteroresistance in C. parapsilosis. Standard antimicrobial susceptibility tests, such as broth microdilution or gradient diffusion assays, which guide drug selection for invasive infections, fail to detect micafungin heteroresistance in C. parapsilosis. To facilitate rapid detection of micafungin heteroresistance in C. parapsilosis, we constructed a predictive machine learning framework that classifies isolates as heteroresistant or susceptible using a maximum of ten genomic features. These results connect heteroresistance to unexplained antifungal prophylaxis failure in allo-HCT recipients and demonstrate a proof-of-principle diagnostic approach with the potential to guide clinical decisions and improve patient care.
引用
- Zhai B, Liao C, Jaggavarapu S, et al. Antifungal heteroresistance causes prophylaxis failure and facilitates breakthrough Candida parapsilosis infections. Nat Med. 2024. PMID: 39095599. doi:10.1038/s41591-024-03183-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。